David B. Rosen

Chief Executive Officer at Dash Pharmaceuticals LLC

66 year

Consumer Services

Retail Trade

Health Technology

Profile

David B.
Rosen is the founder of Dash Pharmaceuticals LLC.
Prior to founding Dash Pharmaceuticals LLC, he worked as Senior Vice President of Business Development at Actylis Corp.
and as Senior Vice President at Rising Pharmaceuticals, Inc. He completed his undergraduate degree at Queens' College Cambridge.

David B. Rosen active positions

Companies	Position	Start
Dash Pharmaceuticals LLC Dash Pharmaceuticals LLC Medical DistributorsDistribution Services Part of NATCO Pharma Ltd., Dash Pharmaceuticals LLC is a front-end pharmaceutical sales, marketing and distribution company. The company is based in Upper Saddle River, NJ. The company was founded by Julie Trendowicz, Nick DiMaio, David B. Rosen. David B. Rosen has been the CEO since incorporation. Dash Pharmaceuticals was acquired by NATCO Pharma, Inc. on January 01, 2022 for $18 million.	Chief Executive Officer	-

All active positions of David B. Rosen

Former positions of David B. Rosen

Companies	Position	End
Rising Pharmaceuticals, Inc. Rising Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Rising Pharmaceuticals, Inc. engaged in selling niche pharmaceutical products. It offers Amiloride Hydrochloride tablets, Anastrozole tablets, Benazepril, Bethanechol, Carisoprodol, Cetirizine Hydrochloride, Cevimeline Hydrochloride, Chloroquine Phophate, and Ciprofloxacin Opthalmic Solutions. The company is headquartered in Saddle Brook, NJ.	Corporate Officer/Principal	31/12/2013
ACETO CORPORATION	Corporate Officer/Principal	-

See the detail of David B. Rosen's experience

Training of David B. Rosen

Queens' College Cambridge

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David B. Rosen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Rising Pharmaceuticals, Inc. Rising Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Rising Pharmaceuticals, Inc. engaged in selling niche pharmaceutical products. It offers Amiloride Hydrochloride tablets, Anastrozole tablets, Benazepril, Bethanechol, Carisoprodol, Cetirizine Hydrochloride, Cevimeline Hydrochloride, Chloroquine Phophate, and Ciprofloxacin Opthalmic Solutions. The company is headquartered in Saddle Brook, NJ.	Retail Trade
Actylis Corp. Actylis Corp. Pharmaceuticals: GenericHealth Technology Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY.	Health Technology
Dash Pharmaceuticals LLC Dash Pharmaceuticals LLC Medical DistributorsDistribution Services Part of NATCO Pharma Ltd., Dash Pharmaceuticals LLC is a front-end pharmaceutical sales, marketing and distribution company. The company is based in Upper Saddle River, NJ. The company was founded by Julie Trendowicz, Nick DiMaio, David B. Rosen. David B. Rosen has been the CEO since incorporation. Dash Pharmaceuticals was acquired by NATCO Pharma, Inc. on January 01, 2022 for $18 million.	Distribution Services

See company connections

Stock Market
Insiders
David B. Rosen